SAN DIEGO, CA, May 2 /PRNewswire-FirstCall/ - Stressgen Biotechnologies Corporation today announced that Gregory M. McKee, President and Chief Executive Officer, will present a corporate update at the BioFinance 2006 Conference on Wednesday, May 3, 2006, at 10:00 am ET at the Toronto Marriott Eaton Centre Hotel in Toronto.
About Stressgen Biotechnologies Corporation:
--------------------------------------------
Stressgen is developing innovative therapeutics for the treatment of viral infections, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol SSB. For more information about Stressgen, please visit the website located at www.stressgen.com.
Donna Slade Director, Investor Relations 6055 Lusk Boulevard San Diego, CA USA 92121 Tel: 858.202.4900 Dir: 858.202.4945 dslade@stressgen.com
Stressgen Biotechnologies Corp.
CONTACT: Donna Slade, Director, Investor Relations, 6055 Lusk Boulevard,San Diego, CA, USA, 92121, Tel: (858) 202-4900, Dir: (858) 202-4945,dslade@stressgen.com
